Researchers at the University of Málaga in Spain have identified senescent astrocytes – a type of star-shaped brain cell – as potential therapeutic targets in Alzheimer’s disease. The findings, stemming from work within the NeuroAD group (Neuropathology of Alzheimer’s Disease) in the Department of Cell Biology, Genetics and Physiology, represent a significant step forward in understanding the cellular mechanisms underlying the neurodegenerative condition.
The research team, affiliated with the IBIMA–BIONAND Platform and CIBERNED, focused on the role of astrocytes, which are crucial for maintaining the brain’s environment and supporting neuronal function. Their work suggests that these cells undergo a process of senescence – a state of irreversible cell cycle arrest – in the brains of Alzheimer’s patients. This senescent state appears to contribute to the disease’s progression.
While the precise mechanisms by which senescent astrocytes contribute to Alzheimer’s are still under investigation, the discovery opens avenues for developing therapies aimed at either preventing astrocyte senescence or mitigating its harmful effects. This approach differs from many current Alzheimer’s research efforts, which primarily focus on amyloid plaques and tau tangles, the hallmark protein aggregates associated with the disease.
Recent studies have highlighted the complexities of Alzheimer’s disease modeling, with differences observed between human and mouse models in how amyloid deposition and microglia responses occur. Research published in Wiley Online Library demonstrates that Alzheimer’s seeds from humans and mice affect amyloid deposition and microglia-dependent plaque responses differently in aged mice, underscoring the challenges in translating findings from animal studies to human treatments.
The University of Málaga’s research builds on a growing body of evidence suggesting that glial cells – including astrocytes and microglia – play a more active role in Alzheimer’s pathology than previously thought. The identification of senescent astrocytes provides a specific cellular target for intervention, potentially leading to more effective therapies.
Alongside this cellular-level research, other innovative approaches are being explored. A European project based in Malaga is investigating the potential of carob pods in combating Alzheimer’s, demonstrating a diverse range of research avenues currently being pursued.
The NeuroAD group has not yet announced specific timelines for clinical trials or the development of targeted therapies. Further research is planned to fully elucidate the role of senescent astrocytes in Alzheimer’s disease and to identify potential therapeutic strategies.
